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Abstract Adherence of monocytes to endothelial cells and 
subsequently to basement membrane represents the initial steps 
in monocyte migration from the vasculature to the interstitium. 
We investigated the role of adhesion to endothelial cells and 
basement membrane in the induction of the cytokine IL-I[~. We 
demonstrated that mRNA for IL-I[~ is induced in adherent THP- 
1 cells, but not in a matrix-specific manner. Adherence to 
fibrinogen, however, causes an increase in mRNA for IL-I[~. A 
background level of IL-1 [~ mRNA induction was observed in cells 
adherent o all matrices, including the non-specific human serum 
albumin substrate, as compared to non-adherent cells cultured in 
teflon troughs. In addition, antibodies to CDl la ,  CDl lb,  [~i 
integrin, VLA4, c¢v[~3 (VNR), and ICAM-1 did not induce 
significant IL-I[~ mRNA when THP-1 cells were adherent to 
those immunoglobulins. THP-1 cells adherent to immune 
complexes of anti-CDlla, anti-CDllb, anti-VLA4, anti-VNR, 
and anti-ICAM-I showed greater mRNA induction than cells 
adherent to primary antibodies alone. THP-1 cells adherent to 
non-specific immune complexes gave the highest level of mRNA 
induction. Secretion of IL-I[~ protein, measured by ELISA at 
24 h, was greatest when cells were adherent to immobilized 
immune complexes or to fibrinogen. Our results demonstrate that 
a general adherence-induced increase in IL-I~ gene expression is 
greatly enhanced by the presence of immune complex. 
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1. Introduction 
Monocytes are recruited to sites of inflammation and infec- 
tion. During their emigration from the peripheral blood, they 
interact with adhesion receptors on the endothelial cells and 
ultimately come into contact with extracellular matrix pro- 
teins. Monocytes express a variety of integrins, receptors for 
extracellular matrix proteins. Interactions of these integrins 
with their ligands are known to have major effects on mono- 
cyte function and maturation including stimulation of secre- 
tion of cytokines, cytotoxicity, and gene expression [1-6]. 
Among the extracellular matrix proteins that interact with 
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monocyte adhesion receptors are fibronectin, vitronectin and 
collagen. Monocytes interact with these matrix components 
through members of the [31 and 133 integrin families. 
Monocytes also recognize and adhere to cell surface mole- 
cules on endothelial cells lining capillaries and venules, includ- 
ing the counter receptors intercellular adhesion molecule-1 
(ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). 
These cell surface proteins are cytokine inducible and are 
known to be involved in the emigration of immune cells. 
Monocytes interact with VCAM-1 through the c~4131 
(VLA4) cell surface receptor [7], with fibronectin through 
c~5131 and VLA4, and with ICAM-1 and fibrinogen through 
Mac-I [8,9]. These interactions with the endothelial cell may 
also result in altered gene expression and further stimulation 
of the monocyte [5]. 
In addition, monocytes express FcRyI, FcRTII and FcRTIII, 
receptors for IgG. These receptors transduce signals resulting 
in tyrosine phosphorylation f p72 syk, the Fc receptor gamma 
chain and paxillin, and the induction of cytokine gene expres- 
sion [10,11]. Previous studies have shown that cross-linking 
the Fc receptors on monocytes will induce production of tu- 
mor necrosis factor-c~ (TNF-a) and interleukin-6 [11,12]. A 
recent study observed activity of Mac-1 in polymorphonuclear 
cells after engagement of Fc~/RII resulting in tyrosine phos- 
phorylation [13], suggesting that signals transduced by Mac-1 
and FcTRII in monocytes may also be coordinated. 
Adherence of monocytes/macrophages to specific substrates 
results in transcriptional upregulation of a variety of genes 
[4,5,14~17]. In addition, Yurochko et al. [18] demonstrated 
that direct engagement of the [31 integrin, but not the 132 
integrin, by antibody crosslinking of the integrin receptor e- 
sults in the upregulation of several immediate arly genes. 
Among the immediate arly genes that are induced by adher- 
ence and/or cross-linking with antibodies are interleukin-l~ 
(IL-I~), TNF-c~, interleukin-8 (IL-8), c-myc, c-myb, and the 
inhibitor of kappa-B [19]. Lin et al. [20] showed that tyrosine 
phosphorylation of a 76 kDa protein coincided with adher- 
ence-induced IL-I[~ message induction in human monocytes. 
In the present study we tested the hypothesis that engage- 
ment of the integrin receptors by adherence to their natural 
ligands would result in the transcriptional upregulation of IL- 
113 in the monocytic ell line, THP-1 cells. In addition, we 
investigated the possibility that the signals transmitted after 
engagement of the immunoglobin receptor, FcRTI or FcRTII, 
by IgG or immune complexes would induce IL-I[3 gene ex- 
pression when cells are adherent. 
2. Materials and methods 
2.1. RNA isolation and PCR 
Total RNA was isolated from THP-1 cells using RNAzol following 
0014-5793196/$12.00 © 1996 Federation of European Biochemical Societies. All rights reserved. 
PH S00 l 4- 5793 (96)00960-X 
242 R.R. Cobb, J.L. Molony/FEBS Letters 394 (1996) 241~46 
the protocol described by the manufacturer (BioTecX, Houston, TX). 
RNA quantitation was determined by the absorbance at 260 nm. A 
total of 1 lag of total RNA was used as template for first strand 
synthesis using reverse transcriptase (RT) and oligo-d(T) and the 
RNA PCR kit (Perkin/Elmer, Branchburg, NJ) in a final volume of 
20 lal following the procedures of the manufacturer. Following first 
strand synthesis, each sample was diluted 1:5 with dH20. 4 lal of each 
diluted sample was then used as template in each of the following 
polymerase chain reaction (PCR) amplifications. PCR primer pairs 
for human IL-113, IL-8, TNF-ct, and 13-actin were purchased from 
Clontech (Palo Alto, CA). PCR reactions were performed using the 
RNA PCR kit and 1 lal of each primer from Clontech as recom- 
mended. The amplified samples were then subjected to agarose gel 
electrophoresis u ing a 3% agarose gel (3:1 NuSieve GTG (FMC, 
Rockland, ME) to ultrapure agarose (Life Technologies, Gaithers- 
burg, MD)). Polaroid pictures were taken with Type 665 film and 
the negatives were scanned using a Molecular Devices Image Ana- 
lyzer. 
Data was quantitated by dividing each sample intensity for 13-actin 
by the mean of intensities for I]-actin (S~act/M[~act X 100 = U~A~). Each 
mRNA specific amplified product band intensity, I was then divided 
by CA, (I/6~/o = In) yielding the RNA specific amplified product-con- 
centration-normalized intensity. These RNA-concentration normal- 
ized sample values (IH) were then divided by the intensity obtained 
using human serum albumin (HSA) as a substrate, and subtracting 
1 from all resulting numbers. [(In/IRsA)--I] = percent mRNA induced 
above background. The final readout thus represents the message 
induced above adherence-induced background (i.e. HSA as a sub- 
strate). 
2.2. Substrate preparation and cell culture 
For preparation of substrates, proteins were isolated as follows. 
Fibronectin was isolated from human serum by gelatin-Sepharose, 
and was the kind gift of Dr. Dawn Nowlin (Tanabe Research Labora- 
tories). The protein was diluted to 100 gg/ml in sterile dH20 at 37°C. 
Fibrinogen was purchased from Sigma (St. Louis, MO), and was 
diluted into sterile dH20 at 100 lag/ml. Vitronectin was purchased 
from Chemicon and diluted to 100 lag/ml in sterile dH20. Recombi- 
nant ICAM-1 was isolated from membrane extracts of $2 cells which 
overexpressed ICAM-1 (Cobb and Molony, unpublished results). 
ICAM-I was purified by chromatography on a column of MEMI 11 
(MediCon, Carpenteria, CA) anti-ICAM-1 eluted with 50 mM CAPS, 
pH 11. ICAM-1 concentration was quantitated by ELISA (R&D 
Systems, Cambridge, MA). ICAM-1 was used at concentrations rang- 
ing from 50-100 ng/ml. Recombinant VCAM-1 was isolated from $2 
cells which overexpress human VCAM-1 [21] and used in similar 
concentrations a  ICAM-1. Antibodies were used as pure IgG, except 
for anti-vitronectin receptor clone LM609, which was clarified ascites. 
Anti-LFA-1, anti-VLA4, anti-MAC-l, anti-ICAM-1, and anti- 
VCAM-1 were obtained from ImmunoTech (formerly AMAC, Inc., 
Cambridge, MA). Anti-I]l (AB1938) and LM609 (MAB1976) were 
obtained from Chemicon (Temecula, CA). All monoclonal antibodies 
used in this study were IgG1 isotype and were diluted from stocks of 
200 lag/ml. Ovalbumin (Oval) was obtained from Sigma. Anti-ovalbu- 
min, goat-anti-rabbit and goat-anti-mouse purified IgG were obtained 
from Organon Teknika/Cappel (Durham, NC). HSA was obtained 
from Intergen (Purchase, NY), and prepared as a 3% solution in 
sterile dH20. Antibodies were used at 2 lag/ml, except as noted for 
dose-response tudies. Immune complex solutions were diluted from 
stocks which contained 100 lag/ml anti-ovalbumin IgG (Cappel) and 
100 lag/ml ovalbumin. Dose-response tudies used serial dilutions of a 
100 gg/ml stock solution (1:1 to 1:100) of the immune complexes, 
consisting of the primary and secondary antibodies, which were 
then allowed to bind to the plates. The plates were then blocked 
with HSA and washed. Constant amounts of fibronectin or ovalbu- 
min (50 lag) were then added to the appropriate wells. 
All substrates were prepared by dilution into sterile dH20 or sterile 
phosphate-buffered saline (PBS) (Gibco). All substrates and antibod- 
ies were sterile filtered and tested for endotoxin using ICN EndoTest 
(ICN, Aurora, OH) tubes prior to use. Endotoxin contaminated sub- 
strates were not used. Substrates (50 lal of each substrate solution per 
well) were incubated on Xenobind activated plates at room tempera- 
ture for at least 2 h followed by storage overnight at 4°C. When 
multiple preparations were called for, plates were blocked with HSA 
before addition of secondary substrate or antibody. In the case of 
immune complex with VLA4, betal, VNR, LFA-1, and Mac-l, the 
complex is composed of the primary antibody to the particular pro- 
tein and the secondary antibody rather than employing isolated pro- 
tein. Therefore, plates were coated with secondary antibody, blocked 
with HSA, washed and then incubated with primary antibody, fol- 
lowed by another HSA blocking step and washes. Further steps were 
performed according to the manufacturer (Xenopore Corp., Saddle- 
brook, N J). 
THP-I cells were grown in spinner flasks or T-75 Corning flasks in 
RPMI (Sigma, St. Louis, MO)+glutamine (Gibco)+pen/strep (Gibco). 
5% CPSR-2 (Sigma), a serum substitute, was used to reduce consti- 
tutive activation of monocytic ells. THP-I cells were washed with 
RPMI (with glutamine and pen/strep) without serum or CPSR-2, 
and resuspended in that medium. Cells were then added to substrate 
or HSA coated wells and incubated at 37°C for 4 h. For measurement 
of IL-II3 production/secretion, 2% CPSR-2 was included in the media, 
and the incubation time was 24 h rather than 4 h to allow synthesis of 
new proteins. IL-I[3 protein levels were measured by ELISA (Endo- 
gen, Boston, MA). The antibody used in this ELISA kit predomi- 
nantly recognizes the mature form of IL-113. 
Cells were plated at 300000 350000 cells/well. Typically, 12 wells 
(1 row) of a 96-well plate were pooled for isolation of IL-1[3 in the 
supernatant and/or preparation of total RNA from the cell pellet. 
3. Results 
3.1. Cytokine gene induction & adherent THP-1 cells 
To investigate the role of general adhesion in the induction 
of gene expression, non-adherent THP-1 cells were incubated 
in teflon troughs in RPMI  media without serum. The cells 
were then exposed to LPS with and without serum. Total 
RNA from each sample was then subjected to RT/PCR to 
examine induced gene expression of the cytokine genes for 
IL-I[3, IL-8, and TNF-ot. The results are shown in Fig. 1. 
mRNA for the different cytokines was induced at varying 
levels depending on treatment. IL-I[3, IL-8 and TNF-~ gene 
induction was observed in the presence of LPS with and with- 
out serum. 
3.2. Role of adhesion receptors of the ~1 and ~3 subfamilies 
In order to determine the matrix specificity of IL-1]3 gene 
expression in THP-1 monocytes, we coated tissue culture 
flasks or pre-activated 96-well plates with a variety of sub- 
strate proteins. Cells allowed to adhere to HSA or plastic 
showed gene induction above the levels seen for non-adherent 
cells, as predicted from previous work by Rosette and Karin 
[22]. As can be seen in Fig. 2A, neither VCAM-1 nor vitro- 
nectin-coated plates stimulated increases of IL-113 mRNA 
above this background level. Adhesion of THP-1 cells to fi- 
bronectin did result in a modest induction of IL-1]3 mRNA.  
In contrast, adhesion of THP-1 cells to fibrinogen resulted in 
a consistent and significant induction of IL-113 mRNA.  
Adherence of THP-1 cells to anti-vitronectin receptor anti- 
bodies C~v[33 (LM609) (VNR) and antibodies to the cq chain 
of VLA4 resulted in no significant upregulation of IL-113 
mRNA.  However, adherence to immune complexes formed 
by crosslinking VLA4 and VNR antibodies timulated IL-1]3 
mRNA production. 
Similar studies were performed to determine if IL-8 mRNA 
was induced by adherence to matrix substrates or immune 
complexes (Fig. 2B). Induction of IL-8 mRNA in THP-I  cells 
exposed to plastic coated with HSA or any substrate, anti- 
body, or immune complexes was minor in comparison to in- 
duction of IL-113 mRNA.  Similar results were seen with TNF-  
mRNA (data not shown). 
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3.3. Role of [12 integrins in induction of  cytokine gene 
expression 
We next examined cytokine mRNA expression as a func- 
tion of 132 integrin-mediated adhesion of THP-1 cells. We 
allowed the cells to adhere to plastic coated with purified 
recombinant human ICAM-1, or to antibodies to CDl la  
(IOTI6), CD l lb ( IOM1)  and ICAM-1 (84H10). As shown in 
Fig. 3, adherence to ICAM-1 did not result in any significant 
upregulation of IL-113 mRNA when compared to mRNA in- 
duced in cells plated on HSA-coated plastic, and compared to 
~-actin controls. In addition, no significant increase in mRNA 
was observed when THP-1 cells were allowed to adhere to 
antibodies to LFA-1, Mac- l ,  or ICAM-1. However, mRNA 
induction was observed in THP-1 cells adherent o immune 
complexes of anti-CD1 la, anti-CDl lb and anti-ICAM-1. 
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Fig. 2. Effects of I~1, ~3, or Fc receptor engagement on IL-113 and 
IL-8 gene induction. Cells were allowed to adhere to 96-well dishes 
coated with different substrates and RT/PCR analysis was per- 
formed after total RNA was isolated. Results are presented as per- 
cent of the normalized intensity of the RT/PCR band in the sample 
of the cells allowed to adhere to HSA. Each sample was repeated a
minimum of four times. (A) IL-I[~ gene induction in THP-1 cells al- 
lowed to adhere to different substrates. (B) IL-8 gene induction in 
THP-1 cells allowed to adhere to different substrates. 
TNF-(x 
Fig. 1. RT/PCR analysis of THP-1 cells. THP-1 cells grown in Tef- 
lon coated dishes (non-adherent, NAD), treated with or without 
LPS. The figure is a representative experiment of four. 
No significant induction of IL-8 mRNA was seen as a result 
of cell adherence to any of the 132 integrin antibodies, sub- 
strates or immune complexes tudied here (Fig. 3B). Similar 
results were seen with TNF-~ (data not shown). 
3.4. Dose response of Fc receptors to immune complex 
To further investigate a possible role of the Fc receptor in 
upregulating ene expression, serial dilutions (1 : 1 to 1:100) of 
complexes formed with secondary antibody and primary anti- 
body to VLA4, fibronectin, or ovalbumin were coated on 96- 
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well plates and subsequently blocked with HSA. A constant 
amount of fibronectin (50 ~tg) was then added to the 1:1, 
1:10, and 1:100 dilutions of anti-fibronectin+anti-rabbit IgG 
or a constant amount of ovalbumin (50 I-tg) was added to the 
anti-ovalbumin dilutions+anti-rabbit IgG. THP-1 cells were 
allowed to adhere as in the other experiments and the total 
mRNA was isolated. As shown in Fig. 4, there was a dose- 
responsive increase in the amount of IL-113 mRNA observed. 
IL-8 and TNF-ct mRNA were induced by adherence to im- 
mune complex, however, the amount of mRNA for IL-8 and 
TNF-et demonstrated a less pronounced ose-responsive effect 
as compared with IL-I~. 
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Fig. 3. Effects of [32 or Fc receptor engagement on IL-I[3 and IL-8 
gene induction. Cells were allowed to adhere to 96-well plates 
coated with different substrates and RT/PCR analysis was per- 
formed after total RNA isolation. Each sample was repeated a 
minimum of four times. (A) IL-I[3 gene induction in THP-1 cells al- 
lowed to adhere to different substrates. (B) IL-8 gene induction in 
THP-1 cells allowed to adhere to different substrates. 
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Fig. 4. Dose-response ffects of immune complex on cytokine 
mRNA induction in THP-I cells. THP-1 cells were allowed to ad- 
here to the various doses of substrates as described. RT/PCR analy- 
sis was performed after total RNA was isolated. Lanes: 1, VLA4 
IC 1:1; 2, VLA4 IC 1:10; 3, VLA4 IC 1:100; 4, fibronectin 50 lag/ 
ml; 5, fibronectin+fibronectin IC 1:1; 6, fibronectin+fibronectin IC 
1:10; 7, fibronectin+fibronectin IC 1:100; 8, ovalbumin 50 lag/ml; 
9, ovalbumin+ovalbumin IC 1:1; 10, ovalbumin+ovalbumin IC 
1 : 10; 11, ovalbumin+ovalbumin IC 1: 100; 12, plastic alone. 
3.5. IL-l[3 secretion is stimulated by adhesion to fibrinogen and 
immune complexes 
To determine if production and secretion of IL-1[~ followed 
the pattern of mRNA induction by matrix, antibody or im- 
mune complex, an ELISA was performed. THP-1 cells were 
incubated for 24 h on matrix, antibody or immune complex. 
IL-1 [3 protein present in the media at 24 h was quantitated by 
ELISA. The results are shown in Fig. 5. Plating THP-1 cells 
on HSA, plastic, and ICAM-1 did not result in IL-I[3 secre- 
tion. However, fibrinogen, fibronectin, as well as anti-LFA-1 
IC and anti-Mac-1 IC, resulted in significant increases in IL- 
l[3 secretion after 24 h. Non-specific immune complexes, oval- 
bumin and anti-ovalbumin, and ovalbumin anti-ovalbumin 
and goat anti-rabbit mmunoglobulin duced the highest lev- 
els of IL-I[3. 
4. Discussion 
Adherence to microvascular endothelium and to extracellu- 
lar matrix is an early event in the process of monocyte mi- 
gration into sites of inflammation or infection [4,23-29]. Re- 
cent studies [4,5,28] have shown that the initial adherence 
event can modulate the expression of inflammatory mediator 
genes. Previous studies have demonstrated that monocyte ad- 
herence to plastic, endothelial cells, or matrix components can 
result in expression of several immediate arly genes [5,16,28]. 
Because previous studies were performed using monoclonal 
antibodies to specific receptors on these cells, and the corre- 
sponding F(ab) fragments recognizing these receptors did not 
induce gene expression, we investigated the possible role of 
the Fc receptors. Furthermore, previous investigations meas- 
ured mRNA induction stimulated by antibody crosslinking 
of cells in suspension [17,18]. In the present study, we com- 
pared the relative effects of direct adhesion to immobilized 
substrates, which involves cytoskeletal signaling as well as 
receptor-specific signals [30,31], on IL-113 gene expression in 
THP-1 cells. 
The adherence of THP-I  cells to the endothelial cell ligands 
ICAM-1 and VCAM-1 does not result in the induction of IL- 
l[3 mRNA accumulation. This observation implies that en- 
gagement of the [31 or [32 integrins may not be sufficient o 
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Fig. 5. IL-I[3 secretion in THP-1 cells exposed to various stimuli. 
THP-1 cells were allowed to adhere to the various substrates for 
24 h. The supernatants were then isolated and assayed for IL-l[3 
protein concentrations u ing an ELISA. 
signal the induction of gene expression. In addition, we show 
that no significant induction of IL-113 mRNA accumulation 
relative to background was observed when THP-1 cells were 
allowed to adhere to monoclonal antibody coated plates. This 
was observed with a variety of different antibodies. The ex- 
periments presented here suggest hat mere engagement of the 
integrin receptor is not sufficient for gene induction. Direct 
adhesion of THP-1 cells to matrix substrates engaging 131 and 
152 integrins is also not sufficient for significant IL-115 gene 
induction. 
Significant increases in IL-115 mRNA accumulation and 
protein secretion were seen when THP-I cells were allowed 
to adhere to crosslinked monoclonal antibodies. This may be 
the result of engagement of integrin receptors in combination 
with recognition of immune complex by the Fc receptor. 
However, the highest amount of gene induction and protein 
secretion was observed with a non-specific immune complex. 
These immune complexes are recognized by the Fc receptors 
on a variety of cells including monocytes. These results imply 
that Fc receptors on THP-1 cells are primarily responsible for 
the increases in IL-113 gene expression observed in experiments 
described herein. 
Our results support the conclusion that the mere engage- 
ment of individual specific integrins on the cell surface of 
monocytes is not sufficient for significant induction of IL-113 
gene expression. The results presented also implicate the Fc 
receptor and the intracellular signals that result from stimula- 
tion through this receptor as primary signals that result in 
gene induction and the subsequent secretion of IL-115. 
Perhaps the role of adhesion in cytokine gene induction is 
regulatory. Secondary signals are required to induce gene ex- 
pression in other systems, such as T-lymphocyte activation, 
where engagement of !31 or 152 integrins is a co-signal for 
proliferation [32 34]. It is likely that secondary signals such 
as endotoxin, cytokines, or immune complexes would be re- 
quired to induce gene expression by monocytic ells such as 
THP-1. For example, evidence has supported the role of 
245 
CDl lb /CD18 as a regulatory integrin for Fc-mediated pha- 
gocytosis in monocytes and neutrophils [13]. 
Alternatively, it is possible that the requirement for second- 
ary signals may be met by recognition of the same matrix 
component by two integrin receptors. This may explain our 
observation that THP-1 cell adherence to fibrinogen stimu- 
lated IL-I[~ mRNA induction and secretion. (Fibrinogen is a 
ligand for both ~3 and ~2 (Mac-l) integrins.) This possibility 
may also explain the results obtained by other researchers 
using peripheral blood monocytes, where the affinities for fi- 
bronectin binding may be similar for both the cq and ct5 
fibronectin receptors, thus resulting in the necessary dual sig- 
nals. Our results with THP-1 binding to fibronectin agrees 
with previous findings. In addition, the data presented here 
demonstrate that Fc receptor engagement significantly en- 
hances IL-113 mRNA induction and protein secretion. 
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